JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,710,634 | +65.0% | 2,546,289 | -1.0% | 0.00% | – |
| Q4 2022 | $2,854,316 | -56.3% | 2,571,456 | -7.8% | 0.00% | – |
| Q3 2022 | $6,526,000 | -19.2% | 2,789,315 | +4.7% | 0.00% | – |
| Q2 2022 | $8,074,000 | -51.8% | 2,664,323 | +8.0% | 0.00% | – |
| Q1 2022 | $16,751,000 | -20.1% | 2,466,858 | -1.8% | 0.00% | -100.0% |
| Q4 2021 | $20,968,000 | +11.3% | 2,511,036 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $18,834,000 | +12.7% | 2,534,851 | +3.2% | 0.00% | – |
| Q2 2021 | $16,708,000 | -11.5% | 2,457,099 | +33.6% | 0.00% | -100.0% |
| Q1 2021 | $18,888,000 | +74.5% | 1,839,299 | +18.9% | 0.00% | – |
| Q4 2020 | $10,826,000 | +9.6% | 1,546,555 | +27.8% | 0.00% | – |
| Q3 2020 | $9,876,000 | +12.6% | 1,210,135 | -4.8% | 0.00% | – |
| Q2 2020 | $8,774,000 | +48.6% | 1,271,654 | +2.3% | 0.00% | – |
| Q1 2020 | $5,903,000 | -45.4% | 1,242,866 | +0.4% | 0.00% | – |
| Q4 2019 | $10,807,000 | +156.7% | 1,238,077 | -2.0% | 0.00% | – |
| Q3 2019 | $4,210,000 | -26.9% | 1,263,831 | +8.6% | 0.00% | – |
| Q2 2019 | $5,760,000 | -18.7% | 1,163,750 | +1.8% | 0.00% | – |
| Q1 2019 | $7,087,000 | +97.4% | 1,143,104 | +7.3% | 0.00% | – |
| Q4 2018 | $3,591,000 | -61.9% | 1,065,339 | -26.6% | 0.00% | – |
| Q3 2018 | $9,429,000 | -11.7% | 1,450,680 | +4.0% | 0.00% | – |
| Q2 2018 | $10,684,000 | -58.1% | 1,394,905 | +22.2% | 0.00% | -100.0% |
| Q1 2018 | $25,519,000 | +72.3% | 1,141,785 | -1.7% | 0.00% | 0.0% |
| Q4 2017 | $14,812,000 | +31.0% | 1,161,840 | +60.1% | 0.00% | 0.0% |
| Q3 2017 | $11,309,000 | +123.8% | 725,726 | +101.5% | 0.00% | – |
| Q2 2017 | $5,054,000 | -12.7% | 360,229 | +36.9% | 0.00% | – |
| Q1 2017 | $5,786,000 | – | 263,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |